LFVN Lifevantage
Lifevantage earnings company data as of 5:01 PM ET 10/23
- 0 of 1 EPS beats
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 3 Nov | EPS | 0.03 | — | — |
| Rev | — | — | — | ||
| FY2026 Q4 | 27 Aug | EPS | 0.15 | 0.11 | Miss -26.7% |
| Rev | $44.0M | $42.4M | Miss -3.6% |
Insider trades
Open-market buys and sales by LFVN's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $196K bought by 2 insiders
- $229K sold by 2 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Darwin Lewis DirectorBuy$6,071 976 shares at $6.22 +0.7% to stakeTraded Sep 15 Filed Sep 17
-
Kristen Cunningham Chief Sales OfficerSale$56K 9,001 shares at $6.18 7% of stakeTraded Sep 11–14 Filed Sep 14
-
Darwin Lewis DirectorBuy$6,059 705 shares at $8.60 +0.5% to stakeTraded Jun 15 Filed Jun 17
-
Michael A Beindorff DirectorSale$85K 10,000 shares at $8.55 19% of stakeTraded Jun 3 Filed Jun 5
-
Darwin Lewis DirectorBuy$5,518 1,055 shares at $5.23 +0.8% to stakeTraded Mar 16 Filed Mar 18
-
Judd Dayton DirectorBuy$152K 33,197 shares at $4.59 +70% to stakeTraded Feb 26–Mar 2 Filed Mar 2
-
Darwin Lewis DirectorBuy$21K 3,955 shares at $5.22 +3% to stakeTraded Feb 9 Filed Feb 11
-
Darwin Lewis DirectorBuy$5,265 805 shares at $6.54 +0.6% to stakeTraded Dec 15, 2025 Filed Dec 17, 2025
-
Michael A Beindorff DirectorSale$81K 12,607 shares at $6.42 22% of stakeTraded Nov 19, 2025 Filed Nov 21, 2025
-
Michael A Beindorff DirectorSale$7,330 1,000 shares at $7.33 2.7% of stakeTraded Nov 7, 2025 Filed Nov 10, 2025
Also filed in the last 12 months, not counted as buying or selling: 16 share withholdings for taxes, 10 stock grants, 2 gifts, and 1 sale to cover taxes.
SEC filings
Recent issuer filings from EDGAR, 16 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.03 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 10-K | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,5.02,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.